IFNA1 and infection: This supports previous findings that connect a delay in type I IFN with more severe presentations of highly pathogenic coronaviruses infections including SARS-CoV, MERS-CoV, and SARS-CoV-2 [10,13,14], and provides a rational explanation for the finding from a retrospective cohort study that early IFN therapy is associated with better responses [28].